Search

Home > GRACEcast Lung Cancer Video > Should EGFR TKI Therapy be Continued Beyond Progression?
Podcast: GRACEcast Lung Cancer Video
Episode:

Should EGFR TKI Therapy be Continued Beyond Progression?
Category: Science & Medicine
Duration: 00:02:52
Publish Date: 2015-10-26 14:00:00
Description:

Dr. Greg Riely, medical oncologist from MSKCC, discusses the controversial question of whether patients should continue on an oral EGFR tyrosine kinase inhibitor after progression.
Total Play: 0